HeimMEHCQ • OTCMKTS
add
23andMe Holding Co.
Við síðustu lokun
1,17 $
Dagbil
1,07 $ - 1,18 $
Árabil
0,48 $ - 12,76 $
Markaðsvirði
30,58 m. USD
Meðalmagn
8,09 m.
V/H-hlutf.
-
A/V-hlutfall
-
Aðalkauphöll
OTCMKTS
Í fréttum
Fjármál
Rekstrarreikningur
Tekjur
Nettótekjur
(USD) | des. 2024info | Breyting á/á |
---|---|---|
Tekjur | 60,26 m. | 34,67% |
Rekstrarkostnaður | 65,06 m. | -22,18% |
Nettótekjur | -53,04 m. | 80,92% |
Hagnaðarhlutfall | -88,01 | 85,83% |
Hagnaður á hvern hlut | — | — |
EBITDA | -21,80 m. | 62,70% |
Virkt skatthlutfall | — | — |
Efnahagsreikningur
Heildareignir
Heildarskuldir
(USD) | des. 2024info | Breyting á/á |
---|---|---|
Reiðufé og skammtímafjárfestingar | 79,35 m. | -67,27% |
Heildareignir | 277,42 m. | -54,39% |
Heildarskuldir | 214,70 m. | -7,06% |
Eigið fé alls | 62,72 m. | — |
Útistandandi hlutabréf | 26,83 m. | — |
Eiginfjárgengi | 0,50 | — |
Arðsemi eigna | -21,15% | — |
Ávöxtun eigin fjár | -42,49% | — |
Peningaflæði
Breyting á handbæru fé
(USD) | des. 2024info | Breyting á/á |
---|---|---|
Nettótekjur | -53,04 m. | 80,92% |
Handbært fé frá rekstri | -44,65 m. | -270,23% |
Reiðufé frá fjárfestingum | 887,00 þ. | 144,09% |
Reiðufé frá fjármögnun | -19,00 þ. | -118,10% |
Breyting á handbæru fé | -43,79 m. | -213,47% |
Frjálst peningaflæði | -20,18 m. | -469,10% |
Um
23andMe Holding Co. is an American personal genomics and biotechnology company based in South San Francisco, California. It is best known for providing a direct-to-consumer genetic testing service in which customers provide a saliva sample that is laboratory analysed, using single nucleotide polymorphism genotyping, to generate reports relating to the customer's ancestry and genetic predispositions to health-related topics. The company's name is derived from the 23 pairs of chromosomes in a diploid human cell.
Founded in 2006, 23andMe soon became the first company to begin offering autosomal DNA testing for ancestry, which all other major companies now use. Its saliva-based direct-to-consumer genetic testing business was named "Invention of the Year" by Time in 2008.
The company had a previously fraught relationship with the United States Food and Drug Administration due to its genetic health tests; as of October 2015, DNA tests ordered in the US include a revised health component, per FDA approval. 23andMe has been selling a product with both ancestry and health-related components in Canada since October 2014, and in the UK since December 2014. Wikipedia
Stofnsett
apr. 2006
Höfuðstöðvar
Vefsvæði
Starfsfólk
571